News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Webcast Alert For Visijet Inc.: Trilogy Capital's Emerging Growth Microcap Forum Announces The Addition Of Two Keynote Speakers To Today's Webcast At 12 P.M. ET


10/19/2005 5:09:15 PM

IRVINE, Calif., Nov. 21 /PRNewswire/ -- VisiJet, Inc. (BULLETIN BOARD: VJET.OB) will webcast the following presentation:

What: VisiJet (BULLETIN BOARD: VJET.OB) will give a presentation at Informed Investors Emerging Growth/Microcap Stocks Forum When: November 21, 2003 @ 12:00 PM Eastern Time Where: http://www.informedinvestors.com/iif_forums/forum.aspx?forumID=339 How: Live over the Internet -- Simply log on to the web at the address above. Contact: AJ Cervantes, Trilogy Capital, aj@trilogy-capital.com, 800-330-1860

If you are unable to participate during the live webcast, the call will be available for replay at http://www.informedinvestors.com/iif_forums/forum.aspx?forumID=339.

The keynote speakers today include Dr. Richard Geist, a well-known commentator, financial analyst and author of the recent national publication, Investment Therapy, available in major bookstores, as well as The Psychology of Investing, which was published in 2001. Dr. Geist appears regularly as an analyst for such programs as CNBC and CNN. In addition, Mr. Paul Cohen, the editor and publisher of the Cohen Independent Research Report will also speak on Microcap investing and the Microcap rationale.

VisiJet, Inc., a medical device company based in Irvine, California, is focused on the development and marketing of innovative ophthalmic applications that will result in faster, safer and more efficacious procedures in two of the largest surgical markets in the world: refractive and cataract surgeries. VisiJet's lead products, the HydroKeratome(R) and Pulsatome(R), utilize the Company's proprietary and patented waterjet technology. These devices uses a high-pressure micro beam of water the diameter of a human hair to cut ocular tissue. The FDA-approved HydroKeratome(R), uses the waterjet technology to cut the cornea as required in LASIK surgery. The Pulsatome(R), currently under development, is a device that uses waterjet technology to remove cataracts -- the most performed surgical procedure in the world.

For more information visit http://www.visijet.com/. About Trilogy Capital

Trilogy's Emerging Growth Microcap Forums, hosted by InformedInvestor.com, provide the perfect online forum for publicizing the compelling stories of potentially high-growth Microcap companies. Trilogy is committed to identifying overlooked and undervalued emerging growth companies that may be poised to revolutionize their fields, create great products and deliver exceptional performance for their investors.

Trilogy Capital Partners, Inc. is a proactive financial services company engaged in corporate communications, investor relations and strategic planning. Based on the simple concept that many well-run public companies are not realizing their full value in the marketplace, Trilogy has aggregated highly experienced executives into a formidable financial and marketing team. Our team utilizes proactive, technology-driven strategies and tools to drive public company visibility. For more information, please visit http://www.trilogy-capital.com/ or contact Racquel Rivera at racquel@trilogy-capital.com.

FORUM CONTACT: Janet Scharr, Informed Investors, 804-327-3424, jscharr@wilink.com

VisiJet, Inc.

CONTACT: AJ Cervantes of Trilogy Capital, aj@trilogy-capital.com or+1-800-330-1860 or Janet Scharr of Informed Investors, +1-804-327-3424,jscharr@wilink.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES